Clinical Trial Update: A Phase III Study in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension in China [Phase 3]

View source ↗

Summary

Phase III clinical trial in China evaluating a treatment for open-angle glaucoma or ocular hypertension is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Hypertension
• Open-angle Glaucoma

Drugs mentioned

• undisclosed

Snippet

Sponsor: Santen Pharmaceutical Co., Ltd. | Conditions: Open Angle Glaucoma, Ocular Hypertension | Phase 3 | Status: RECRUITING